OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Cardiology is 62. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Error in Table 1	444
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?	272
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply	267
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling	259
Primary Prevention Management of Elevated Lipoprotein(a)	233
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP	222
A Woman With Recurrent Torsade de Pointes	185
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious	182
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy	173
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction	164
Chest Pain in a Middle-Aged Man	163
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic	157
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership	154
JAMA Cardiology	150
Accountable Care Organization Participation and Cardiovascular Care Quality	148
JAMA Cardiology	140
Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals	138
Mining the Electronic Medical Record for Hypertension Treatment—Hope or Hype?	128
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction	127
Midlife Wealth Mobility and Long-term Cardiovascular Health	121
USPSTF Report on Aspirin for Primary Prevention	121
Genome-Wide Association Study of Accessory Atrioventricular Pathways	119
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors	109
Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes	102
Blood Pressure Measurements From Self-Service Health Kiosks in US Retail Stores, 2017-2024	102

Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden	101
Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease	101
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF	97
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure	96
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction	95
JAMA Cardiology	94
What Is Your Secret to Health?	92
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply	91
Supraventricular Tachycardia Following Mitral Valve Surgery	89
Assessing Performance of Machine Learning—Reply	86
JAMA Cardiology	85
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	84
Hypertriglyceridemia in the MESA Study—Reply	83
Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US	82
User Trust in Artificial Intelligence–Guided Lung Ultrasound	81
Contribution of Clinical Trial Event Data by Data Source	79
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?	79
Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker	78
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease	78
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction	78
Circulating Trimethylamine N-Oxide and Growth Rate of Abdominal Aortic Aneurysms and Surgical Risk	78
Interpreting Health Status Measures in Patients With Heart Failure—What Counts	77
Innovation in Event Adjudication—Human vs Machine	75
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone	75
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features	74
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy–Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer	74
Peak Oxygen Uptake vs Ventilatory Efficiency	72
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm	71
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts	70
Achieving Equitable Access to Acute Myocardial Infarction Therapies for Rural Patients—Is It Possible?	69
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction	69
Corrected to Open Access Status	65
Change to Open Access Status	65
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	64
Safety of the 4PEPS in Patients With a Very Low Prevalence of Pulmonary Embolism—Need for More Than a Point Estimate—Reply	64
Professional Preferences and Perceptions of Cardiology Among Internal Medicine Residents	64
JAMA Cardiology	63
Error in Figure	62
Young Man With Coarctation of the Aorta	62